99 related articles for article (PubMed ID: 19118520)
1. Thiazolidinediones inhibit REG Ialpha gene transcription in gastrointestinal cancer cells.
Yamauchi A; Takahashi I; Takasawa S; Nata K; Noguchi N; Ikeda T; Yoshikawa T; Shervani NJ; Suzuki I; Uruno A; Unno M; Okamoto H; Sugawara A
Biochem Biophys Res Commun; 2009 Feb; 379(3):743-8. PubMed ID: 19118520
[TBL] [Abstract][Full Text] [Related]
2. REG Ialpha protein mediates an anti-apoptotic effect of STAT3 signaling in gastric cancer cells.
Sekikawa A; Fukui H; Fujii S; Ichikawa K; Tomita S; Imura J; Chiba T; Fujimori T
Carcinogenesis; 2008 Jan; 29(1):76-83. PubMed ID: 18024479
[TBL] [Abstract][Full Text] [Related]
3. Possible role of REG Ialpha protein in ulcerative colitis and colitic cancer.
Sekikawa A; Fukui H; Fujii S; Nanakin A; Kanda N; Uenoyama Y; Sawabu T; Hisatsune H; Kusaka T; Ueno S; Nakase H; Seno H; Fujimori T; Chiba T
Gut; 2005 Oct; 54(10):1437-44. PubMed ID: 15914572
[TBL] [Abstract][Full Text] [Related]
4. Peroxisome proliferator-activated receptor gamma-independent effects of thiazolidinediones on human cardiac myofibroblast function.
Mughal RS; Warburton P; O'Regan DJ; Ball SG; Turner NA; Porter KE
Clin Exp Pharmacol Physiol; 2009 May; 36(5-6):478-86. PubMed ID: 19673929
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor gamma inhibits follicular and anaplastic thyroid carcinoma cells growth by upregulating p21Cip1/WAF1 gene in a Sp1-dependent manner.
Bonofiglio D; Qi H; Gabriele S; Catalano S; Aquila S; Belmonte M; Andò S
Endocr Relat Cancer; 2008 Jun; 15(2):545-57. PubMed ID: 18509005
[TBL] [Abstract][Full Text] [Related]
6. Regenerating gene I regulates interleukin-6 production in squamous esophageal cancer cells.
Usami S; Motoyama S; Koyota S; Wang J; Hayashi-Shibuya K; Maruyama K; Takahashi N; Saito H; Minamiya Y; Takasawa S; Ogawa J; Sugiyama T
Biochem Biophys Res Commun; 2010 Jan; 392(1):4-8. PubMed ID: 20056108
[TBL] [Abstract][Full Text] [Related]
7. REG I enhances chemo- and radiosensitivity in squamous cell esophageal cancer cells.
Hayashi K; Motoyama S; Koyota S; Koizumi Y; Wang J; Takasawa S; Itaya-Hironaka A; Sakuramoto-Tsuchida S; Maruyama K; Saito H; Minamiya Y; Ogawa J; Sugiyama T
Cancer Sci; 2008 Dec; 99(12):2491-5. PubMed ID: 19032369
[TBL] [Abstract][Full Text] [Related]
8. Thiazolidinediones inhibit TNFalpha induction of PAI-1 independent of PPARgamma activation.
Liu HB; Hu YS; Medcalf RL; Simpson RW; Dear AE
Biochem Biophys Res Commun; 2005 Aug; 334(1):30-7. PubMed ID: 15990085
[TBL] [Abstract][Full Text] [Related]
9. Repression of NHE1 expression by PPARgamma activation is a potential new approach for specific inhibition of the growth of tumor cells in vitro and in vivo.
Kumar AP; Quake AL; Chang MK; Zhou T; Lim KS; Singh R; Hewitt RE; Salto-Tellez M; Pervaiz S; Clément MV
Cancer Res; 2009 Nov; 69(22):8636-44. PubMed ID: 19887620
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor-gamma agonists suppress adrenocortical tumor cell proliferation and induce differentiation.
Betz MJ; Shapiro I; Fassnacht M; Hahner S; Reincke M; Beuschlein F;
J Clin Endocrinol Metab; 2005 Jul; 90(7):3886-96. PubMed ID: 15886257
[TBL] [Abstract][Full Text] [Related]
11. Thiazolidinediones inhibit growth and invasiveness of the human adrenocortical cancer cell line H295R.
Ferruzzi P; Ceni E; Tarocchi M; Grappone C; Milani S; Galli A; Fiorelli G; Serio M; Mannelli M
J Clin Endocrinol Metab; 2005 Mar; 90(3):1332-9. PubMed ID: 15585569
[TBL] [Abstract][Full Text] [Related]
12. REG Ialpha protein expression in Barrett's esophagus.
Chinuki D; Amano Y; Ishihara S; Moriyama N; Ishimura N; Kazumori H; Kadowaki Y; Takasawa S; Okamoto H; Kinoshita Y
J Gastroenterol Hepatol; 2008 Feb; 23(2):296-302. PubMed ID: 18289358
[TBL] [Abstract][Full Text] [Related]
13. PPARgamma agonists attenuate proliferation and modulate Wnt/beta-catenin signalling in melanoma cells.
Smith AG; Beaumont KA; Smit DJ; Thurber AE; Cook AL; Boyle GM; Parsons PG; Sturm RA; Muscat GE
Int J Biochem Cell Biol; 2009 Apr; 41(4):844-52. PubMed ID: 18822385
[TBL] [Abstract][Full Text] [Related]
14. PPARgamma ligands suppress the feedback loop between E2F2 and cyclin-E1.
Komatsu Y; Ito I; Wayama M; Fujimura A; Akaogi K; Machida H; Nakajima Y; Kuroda T; Ohmori K; Murayama A; Kimura K; Yanagisawa J
Biochem Biophys Res Commun; 2008 May; 370(1):145-8. PubMed ID: 18355447
[TBL] [Abstract][Full Text] [Related]
15. REG Ialpha is a reliable marker of chemoradiosensitivity in squamous cell esophageal cancer patients.
Hayashi K; Motoyama S; Sugiyama T; Izumi J; Anbai A; Nanjo H; Watanabe H; Maruyama K; Minamiya Y; Koyota S; Koizumi Y; Takasawa S; Murata K; Ogawa J
Ann Surg Oncol; 2008 Apr; 15(4):1224-31. PubMed ID: 18259819
[TBL] [Abstract][Full Text] [Related]
16. Thiazolidinediones inhibit the growth of PC12 cells both in vitro and in vivo.
Kim SW; Choi OK; Chang MS; Shin CS; Park KS; Kim SY
Biochem Biophys Res Commun; 2008 Jun; 371(2):197-202. PubMed ID: 18423377
[TBL] [Abstract][Full Text] [Related]
17. [Anti-cancer action by PPARgamma ligand].
Okumura T
Nihon Rinsho; 2010 Feb; 68(2):267-72. PubMed ID: 20158095
[TBL] [Abstract][Full Text] [Related]
18. REG Ialpha protein may function as a trophic and/or anti-apoptotic factor in the development of gastric cancer.
Sekikawa A; Fukui H; Fujii S; Takeda J; Nanakin A; Hisatsune H; Seno H; Takasawa S; Okamoto H; Fujimori T; Chiba T
Gastroenterology; 2005 Mar; 128(3):642-53. PubMed ID: 15765400
[TBL] [Abstract][Full Text] [Related]
19. Involvement of the IL-22/REG Ialpha axis in ulcerative colitis.
Sekikawa A; Fukui H; Suzuki K; Karibe T; Fujii S; Ichikawa K; Tomita S; Imura J; Shiratori K; Chiba T; Fujimori T
Lab Invest; 2010 Mar; 90(3):496-505. PubMed ID: 20065946
[TBL] [Abstract][Full Text] [Related]
20. Activation of PPARgamma negatively regulates O-GlcNAcylation of Sp1.
Chung SS; Kim JH; Park HS; Choi HH; Lee KW; Cho YM; Lee HK; Park KS
Biochem Biophys Res Commun; 2008 Aug; 372(4):713-8. PubMed ID: 18513490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
